The Magic of Science and How TMS Saved Me

I used to hate magic shows. Nothing frustrated me more than trying to figure out how the guy removes the beautiful woman from the box on stage, only to wow the audience moments later by revealing her—in the flesh—sitting in the theatre’s balcony with a big smile on her face. Magicians will never tell you their secrets, they will never disclose how the rabbit got in the hat, much less how he pulled the poor thing out of it. The stock answer, if ever asked, is a smug, “It’s just magic!” Many years ago I attended a magic show where Read More …

It Started in My Basement, Now it Improves Patients Lives

Charles M. Epstein, MD, or “Chip” as he’s been known since childhood, is a professor of neurology specializing in epilepsy and the founder of  the Laboratory for Transcranial Magnetic Stimulation (TMS). He is also a co-inventor for the technology that is utilized by Emory partner Neuronetics, Inc in their NeuroStar TMS Therapy® for treating depression. Neuronetics has safely administered more than 10,000 NeuroStar TMS Therapy® treatments with clinically significant results: among patients studied, 54 percent responded to the therapy and 33 percent found their depression in remission. Neurostar wasn’t the first technology you were involved with. Could you tell us Read More …

Case Managers’ Reflect on Their Time with TMS

OTT’s first disclosure from Charles “Chip” Epstein, MD related to his work with an iron core stimulation coil was received in the spring of 1995, with a second disclosure related to transcranial magnetic stimulation (TMS) coming along in late 1997. These were not only the early days for the technology but also the early days of our budding Tech Transfer office. The technology looked promising since it was both the first magnetic stimulator to utilize an iron core design which enabled improvements in power efficiency, heat generation, focal stimulation, and costs. Recognizing these benefits, OTT decided to pursue patent protection Read More …